Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults.
Michelle R Lofwall, Roland R Griffiths, Miriam Z Mintzer
Experimental and clinical psychopharmacology November 1, 2006 DOI: 10.1037/1064-1297.14.4.439 via PubMed
Summary
AI-generated from the abstractKetamine, a drug that blocks NMDA receptors, produces selective, temporary, dose- and time-related effects on memory and cognition. In a double-blind, placebo-controlled crossover study, 18 healthy adults received low or moderate doses of ketamine. Ketamine impaired memory encoding (free recall) and working memory speed, but spared retrieval, recognition, source memory, attention, and accuracy on a symbol substitution task. Subjective effects lasted longer than memory or psychomotor impairments, and there were no hallucinations or mystical experiences. The findings help clarify the role of NMDA receptors in different cognitive processes.
Study at a glance
| Characteristics | Randomized controlled trial Placebo-controlled Double-blind Peer reviewed |
|---|---|
| Sample size | 18 |
| Population | Healthy adult volunteers |
| Intervention | Ketamine |
| Dose | 0.2 mg/kg, 0.4 mg/kg |
| Duration | 5 hours after drug administration |
| Keywords | Ketamine study: ketamine Investigated Doses Drug influence Placebo-controlled design |
| Citations | 57 |
| Key finding | Ketamine selectively impairs memory encoding and working memory speed while sparing retrieval, attention, and accuracy. |
Abstract
Ketamine is a noncompetitive N-methyl-D-aspartate (NMDA) antagonist. Given the purported role of the NMDA receptor in long-term potentiation, the primary purpose of the present study was to further understand the dose-related effects of ketamine on memory. The study was also designed to provide information about the relative effects of ketamine on memory versus nonmemory effects and to more fully characterize ketamine's overall pattern and time course of effects. Single intramuscular injections of ketamine (0.2 mg/kg, 0.4 mg/kg) were administered to 18 healthy adult volunteers using a double-blind, placebo-controlled, crossover design. Word lists were used to evaluate episodic memory (free recall, recognition memory, source memory) and metamemory. Working memory, time estimation, psychomotor performance, and subjective effects were assessed repeatedly for 5 hours after drug administration. Ketamine selectively impaired encoding (as measured by free recall) while sparing retrieval, working memory while sparing attention, and digit symbol substitution task speed while sparing accuracy. Ketamine did not significantly impair recognition or source memory, metamemory, or time estimation. There were no hallucinations or increases in mystical experiences with ketamine. Memory measures were less sensitive to ketamine effects than subjective or psychomotor measures. Subjective effects lasted longer than memory and most psychomotor impairments. Ketamine produces selective, transient, dose- and time-related effects. In conjunction with previous studies of drugs with different mechanisms of actions, the observed selectivity of effects enhances the understanding of the pharmacological mechanisms underlying memory, attention, psychomotor performance, and subjective experience.